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INTRODUCTION
Selma M. Lussenburg
It is my great pleasure to be here to chair a panel on financing innovation,
investment in development, and marketing of new technology. I think it is
fair to say that the presentation we just heard serves as an excellent frame-
work for the discussion that is going to follow.
The focus of our discussion today - and we do have a surprise guest that I
will identify shortly - is a look at this topic from two very different perspec-
tives; the first perspective is the initiation of research, identification of oppor-
tunities, and ownership of intellectual property.
In the context of financing innovation, Ted and Joe are going to speak
about the inherent conflict between the institution, which sponsors the re-
search, the innovation and the interests of the individual investigator and
researcher, and the need to protect the intellectual property, which is being
created.
I will give Ted and Joe's background momentarily. Our second perspec-
tive, if you will, starts at the other end of the spectrum, and that is at the end
of business or industry. And the focus of this presentation will be in identify-
ing the need for new technology so going to industry, trying to see what it is
to understand what industry needs to do and then finding the researchers and
technology to support the industrial innovation and growth.
We are fortunate to have three excellent speakers today. From my left to
my right, starting with Joe at the far end, is our unannounced but excellent
speaker, who is going to tandem team with Ted, is Joe Jankowski. He is the
Assistant Vice President of Biomedical Science at Case.
He manages the commercialization function of biomedical technology for
the Case School of Medicine and its affiliates. He sits on the conflict of inter-
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est committee and boards of Case investments, and in his previous life he
was at the Cleveland - was it the Cleveland Foundation Clinic?
DR. JANKOWSKI: Cleveland Clinic Foundation.
MS. LUSSENBURG: Just the Cleveland Clinic Foundation and Battelle.
How apropos given our previous presentation.
Ted and I have to laugh, Ted and I sat on a panel a few years ago, and you
may recall Ted was the one that showed that video in effect about 911 and
power outages, and that following summer we had that massive electrical
outage, and we thought it was a little far fetched. Well, that's Ted.
So I had not put two and two together, and when I saw Ted, I said you
know, I thought you were much older because when I read your profile, I did
not put you in the context with the same man I sat on the podium with two
years before.
Ted started his professional career as a lawyer at Squire, Sanders &
Dempsey L.L.P., focusing on the bond between investment capital and tech-
nology; then moved to The Cleveland Clinic Foundation, which is a local
foundation with approximately $4 billion dollars under investment, which
focuses on the commercialization of technology.1
Today, Ted is the Managing Director and Fund Counsel to Panzica In-
vestments, LLC. He combines his 20 years of experience of business and
legal to structuring investments and buying products and companies to put
more technology into the marketplace and industry.
I am going to introduce Mark first because then we get all the nitty gritty
out of the way. To my immediate left is Mark Romoff. It is a pleasure to
have Mark with us today. He is the President and CEO of the Ontario Centers
of Excellence, which is a leading organization in Ontario to promote innova-
tion and economic development.
Mr. Romoff had a distinguished career in Canadian's Foreign Service
prior to joining the Ontario Centers of Excellence. I hope this is right. He
served as a commercial counselor in Nigeria, Mexico, and Malaysia.
He was the Minister Counsel at the Canadian Embassy in Tokyo, and he
was our Counsel General in Buffalo starting in 1996 and helped establish
policies governing cross border relations between Canada and the United
States. I think we have a panel that is very well equipped to speak to financ-
ing and innovation in the market.
Thank you. Ted and Joe will have 25 minutes, and Mark will have 20
minutes if someone is tracking time.
Thank you.
1 See CLEVELAND CLINIC, TRANSFORMING MEDICINE, 2005 ANNUAL REPORT 50 (2005).
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